MROQC Resources Hub
Welcome to the MROQC Resources hub—your one-stop shop for all key program details, incentive opportunities, participation requirements, and more
BCBSM Incentive Programs:
Pay-for-Performance (P4P):
Blue Cross Blue Shield of Michigan (BCBSM) has a hospital incentive-based program called pay-for-performance, or P4P. The program recognizes hospitals that excel at care quality, cost-efficiency, and population health management.
P4P are incentives based on participation and performance in quality and outcome measures. Each CQI coordinating center develops a performance index and scores each hospital participant.
​​
-
Payment is made in July and tied to the score received based on the previous year’s performance (e.g., 2017 P4P reimbursement will be dispersed in July 2018)
-
A hospital can earn up to 40% of its P4P payment as a result of its participation, depending on how many CQIs they participate in
Gold Card Program:
In 2017, BCBSM/BCN developed and implemented the Gold Card Incentive Program in collaboration with MROQC. Being "Gold Carded" allows select radiation oncologists at facilities who met specific quality improvement criteria to receive auto approval for radiation therapy authorizations submitted to eviCore.
This program is only unique to facilities who have membership in MROQC and that have contributed data to the MROQC’s data registry for at least two years, including at least one year’s worth of baseline data.
Questions for BCBSM/BCN regarding the Gold Card Program may be submitted via goldcardinginquiry@bcbsm.com
CQI VBR:
The Value Partnerships Program at Blue Cross Blue Shield Michigan (BCBSM) develops and maintains quality programs to align practitioner reimbursement with quality of care standards, improved health outcomes and controlled health care costs. Practitioner reimbursement earned through these quality programs is referred to as value-based reimbursement, or VBR. The VBR Fee Schedule sets fees at greater than 100% of the Standard Fee Schedule.
Recently, the Value Partnerships Program expanded their VBR opportunities to Physician Group Incentive Program (PGIP) practitioners who participate in select Collaborative Quality Initiatives (CQIs) and meet specific eligibility criteria. Eligible practitioners receive 103-110% of the standard fee schedule as part of “CQI VBR”.
Currently, MROQC is one of 13 CQIs to offer participating PGIP physicians the opportunity to receive CQI VBR, based on meeting clinical targets relevant to MROQC. MROQC, in collaboration with BCBSM has developed quality and performance metrics for MROQC’s value-based reimbursement.
For an MROQC radiation oncologist to be eligible for CQI VBR, their facility must:
-
Meet the performance targets set by the consortium
-
The radiation oncologist themselves must be a member of a PGIP physician organization for at least one year
-
Have contributed data to the MROQC's data registry for at least two years, including at least one year’s worth of baseline data
FTE Allocation Process:
Current MROQC FTE Funding Model (subject to change annually)
Participating MROQC facilities receive an annual Participation Payment for full-time equivalent (FTE) funding based on their case volume through the generous support of BCBSM-BCN. This payment is intended to cover a portion of data abstraction costs for entering not only BCBSM cases but also those cases who are insured by other payers-including those who are government insured or even uninsured as well (projected to be approximately 84% of total cases).
​
The current MROQC FTE model is based on a facility case volume of 191 patients
FTE=number of cases at a given facility/191
Participation Payments are sent out to our member facility in July (via hospital contracting or payments to free-standing facilities).
A single FTE should be expected to effectively manage 191 eligible cases, and the facility should staff the MROQC project accordingly with a Clinical Data Abstractor (CDA) to coordinate capture of clinical data and patient reported outcomes, AND a physicist or dosimetrist to report technical details of treatment planning and delivery.
MROQC Policies:
MROQC Quality Improvement Plan (QIP)
The purpose of the MROQC Quality Improvement Plan (QIP) is to address underperformance in specific areas within an MROQC facility. If there is a persistent and unexplained trend of declining performance in any of the following identified areas, a facility may be required to develop and implement a QIP.
Attendance Requirements
A collaborative is only as strong as its members. As part of membership in MROQC, BCBSM requires active participation from each member of the consortium and attendance by key members at the MROQC collaborative-meetings is an expectation and scored annually.
Clinical Champion
-
A facility Clinical Champion is expected to attend all of the MROQC Collaborative Meetings held in a calendar year.
-
When the Clinical Champion cannot attend a substitute may be allowed to represent the hospital. A substitute is allowed once a year.
Ideally, the substitute is another Radiation Oncologist from that hospital that treats MROQC patients. Other Radiation Oncologists are acceptable.
-
In certain cases (example: a small facility with only 1-2 Radiation Oncologists), another physician is acceptable such as the Chief Medical Officer (CMO), the Chief of Quality, or a physician involved in Radiation Oncology cases.
-
Residents, Physician Assistants (PA), Nurse Practitioners or non-physicians are not acceptable substitutes.
-
For more information, please see the MROQC CC Attendance Policy
Physics Lead (or designee)
-
The facility’s Physics Lead (or designee-i.e. another physicist or a dosimetrist who works on MROQC) is expected to attend all of the MROQC Collaborative Meetings in a calendar year.
Clinical Data Abstractor (CDA or Designee)
-
A MROQC CDA (or designee-i.e. another CDA or someone who works on MROQC not covering another role at a meeting) is expected to attend all of the MROQC Collaborative Meetings in a calendar year.
Collaborative-Wide Meetings and Slides
All slides and recordings from past meetings are available . Please reach out to support@mroqc.org
with any questions.
May 16th, 2025 (Kellogg Conference Center)
February 28, 2025- Webinar
​
Recordings:
​​
Past meetings slides click Here
Participate in MROQC:
Since 2011, MROQC has been a platform for both comparative effectiveness research and quality improvement. Our work has allowed us to move the needle in a positive direction with clinically meaningful endpoints and our success in breast and lung cancers has allowed us to expand to other clinical indications (bone metastases and prostate cancer). The MROQC Coordinating Center works in partnership with our members by sharing data to develop best practices in areas of care with high variation and costs.
​
To participate in MROQC, a facility must meet the following criteria:
-
Treat a minimum of 150 new breast, lung, and prostate cancer cases per year plus patients being treated for bone metastases (with a primary cancer of: breast, lung, prostate, melanoma or renal cell)
-
Identify a radiation oncologist Clinical Champion to lead participation in collaborative quality improvement efforts
-
Identify an onsite medical physicist to act as the Physics Lead.
-
Designate a representative from Physics/Dosimetry to collect dosimetry data for patients enrolled.
-
Identify an administrative champion to act as the Administrative Lead.
-
Engage and/or hire appropriate Clinical Data Abstractor (CDA) support
-
Identify and enroll all eligible patients to the MROQC projects
-
Commit to active participation in collaborative quality improvement activities
-
Contribute case data to the MROQC database in a timely manner
-
Collaborate with the MROQC coordinating center and other participating facilities, including sharing and learning from best practices
​
​
Contact Us:
For more detailed information on how your facility can join MROQC, please email the MROQC Managing Director, Melissa Mietzel, at hillmel@med.umich.edu
​
​
Continuing Education for MDCB, ARRT, & ASRT
​To receive MDCB/ARRT/ASRT credits for attending an in-person MROQC Consortium Meeting and the Physics Breakout Session, a link will be provided to those who were in attendance.
* MROQC does not provide MDCB/ARRT/ASRT credit for virtual meetings.
​​​​​
Medical Dosimetrist Certification Board (MDCB)
You will be asked to provide your CMD ID with your request. Your attendance at qualifying meeting(s) will be reported by MROQC to MDCB using their approved Activity Upload Roster.
​​
This means:
-
By utilizing their Activity Upload Roster, you will not be issued certificates to receive MDCB credit.
-
You will also not need to manually add the activity to your learning plan as submission of the roster will auto-populate individual CMD learning plans/transcripts with this activity as complete and accepted
American Registry of Radiologic Technologists (ARRT) & American Society of Radiologic Technologists (ASRT):
-
For self-reporting to ARRT and/or ASRT, please request a certificate(s) of completion using the link received